Blood Gas Analyzers and Monitors Penetrate Europe's Hospitals

The ability to provide speedy results is boosting penetration rates of blood gas analyzers and monitors across Europe's hospitals. The ability to deliver vital parameters instantaneously has driven the market, while creating extremely lucrative growth opportunities.

Frost & Sullivan (Palo Alto, CA, USA), an international growth consultancy company, finds that the European Blood Gas Analyzers and Monitors Market will earn revenues of US$360.5 million in 2006 and estimates this to reach $470.0 million in 2013.

"The growing need for immediate bedside results, coupled with the rising patient population, has led to the enhanced penetration of blood gas monitors and analyzers,” said Frost & Sullivan research analyst C.R.Hema Varshika. "Laboratory tests that used to take around 30 minutes for the result to be obtained are now a thing of the past; currently manufactured point-of-care devices yield immediate answers.”

Regulatory problems and competition from local participants constitute the main challenges in the market. Each country has a distinct system of purchasing equipment and this disparity can only be overcome once countries adopt uniform laws. At the same time, high levels of brand consciousness among hospitals and intense competition from local participants will deter prospective market entrants.

"Increased penetration in this mature market can be achieved only through innovative products and effective marketing strategies,” advised Ms. Varshika. "Proactive marketing of technologically advanced and user-friendly products will lead to a rise in market share.”



Related Links:
Frost & Sullivan